Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > VOC's & elevated levels of endotoxins

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Nov 26, 2021 3:08pm

145 Views

Post# 34170384

RE:VOC's & elevated levels of endotoxins

MM We have mounting and explicit evidence of the utility of PMX in treating Covid in the wake of a 2/3rd sell off. Any chance the 2 situations are related.

my thought is that they are not. These articles are far too complex for the peripheral reader to digest and associate to Spectral so there is little threat to the company that these will move the SP. And the share price seems to be where it is for no other reason than to make the company look rotten and keep potential buyers away.

<< Previous

Bullboard Posts

Next >>

10 common investing mistakes to avoid